|Articles|December 1, 2012
- Pharmaceutical Executive-12-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - December 2012
The Puzzle Master
Advertisement
Articles in this issue
over 13 years ago
Obamacare, Innovation and Pricingover 13 years ago
Germany's Price Reform Revolutionover 13 years ago
Transforming Drug Development: A Lilly–Covance Case Studyover 13 years ago
The Puzzle Master: EMA's Guido Rasiover 13 years ago
Top Medical Innovations for 2013Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5